Welcome to LookChem.com Sign In|Join Free
  • or
4-{4-[bis-(4-methoxy-phenyl)-methylene]-7-methoxy-chroman-2-yl}-phenol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

919112-04-2

Post Buying Request

919112-04-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

919112-04-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 919112-04-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,9,1,1 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 919112-04:
(8*9)+(7*1)+(6*9)+(5*1)+(4*1)+(3*2)+(2*0)+(1*4)=152
152 % 10 = 2
So 919112-04-2 is a valid CAS Registry Number.

919112-04-2Downstream Products

919112-04-2Relevant academic research and scientific papers

Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reaction

Gupta, Atul,Dwivedy, Anila,Keshri, Govind,Sharma, Ramesh,Balapure, Anil Kumar,Singh, Man Mohan,Ray, Suprabhat

, p. 6006 - 6012 (2007/10/03)

7-Methoxy-4-(4-methoxybenzylidene)-2-substituted phenyl-benzopyrans I and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans II carrying different alkylamino residues, designed as estrogen receptor (ER) binding ligands, were successfully synthesized through the McMurry coupling reaction of substituted benzaldehyde/substituted benzophenones and 2-hydroxyphenyl-7-methoxy-chroman-4-one in presence of lithium aluminum hydride and titanium (IV) chloride (LAH-TiCl4). Self-coupling of carbonyl reactants led to the formation of several side products. The prototypes were evaluated for their relative binding affinity (RBA), as well as their estrogenic and antiestrogenic activities. High order of estrogenic activity (>50% gain) observed with compounds 3, 7a, 7b, 7c, 8, and 10a and also their partial estrogen antagonistic activity (≥15%) at the uterine level points toward successful designing of the compounds. Compounds 4, 7a, 7b, 7c, and 10a also possessed significant anticancer activity against human adenocarcinoma cell line (MCF-7 cell line) that may be related to their estrogen-dependent action.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 919112-04-2